Therapeutic potential of extracellular vesicles in inflammatory diseases
Extracellular Vesicle, ISSN: 2773-0417, Vol: 5, Page: 100058
2025
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Review Description
Extracellular vesicles are spherical lipid bilayer vesicles composed of lipids, proteins and nucleic acids that could deliver signaling molecules into target cells to regulate their function and biological processes. Recently, increasing numbers of studies have demonstrated the therapeutic potential of extracellular vesicles (EVs) in inflammatory diseases by migrating the inflammatory responses and ameliorating physiological deteriorations, as well as promoting angiogenesis and mediating immune responses. In this review, we mainly focused on the biological and molecular functions of EVs in anti-inflammatory activity and their protective roles in many kinds of inflammation diseases, including pneumonia, neuroinflammatory diseases, inflammatory bowel disease, osteoarthritis, rheumatoid arthritis, cardiovascular disease, dry eye disease, periodontitis, diabetic wounds and systemic lupus erythematosus. Furthermore, we further summarized the underlying therapeutic mechanisms of EVs in inflammatory diseases and discussed the current challenges and future perspectives of EVs in clinical applications, providing an insight into the potential of EVs as therapeutic agent for other diseases.
Bibliographic Details
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know